personal protective equipment (PPE); however, hospital supplies were subsequently assured and local policies changed. Fortunately, we were able to avoid reliance on teledermatology and its associated limitations that may miss important diagnoses. 6 Acute dermatitis featured more in 2020, similar to findings from other countries, 5 and as expected subacute referrals reduced (e.g. NMSC). Interestingly, there was a rise in scabies presentations, which was experienced by other local private practices. This is contrary to the expectation that lockdown and social distancing would reduce opportunities for intimate or close contact. Similar observations have been made regarding sexually transmitted diseases, wherein delayed diagnosis can have more serious implications. 4,5,7 It is thus important to encourage testing for STIs despite COVID-19. Unlike our international counterparts, we did not experience a sustained significant reduction in consults and have not needed to dramatically change our practice. However, the long-term consequences of potentially delayed diagnosis of subacute conditions in Australian dermatology practice need to be further evaluated, including trends in private and primary care practices. Our experience also shows that demand for hospital dermatology services continues and departments should learn from the experiences of international counterparts for better preparedness for future pandemics.
ETHICALEthical committee review was not sought as guided by the 2014 NHMRC Guidelines for Quality Assurance and Evaluation Activities, and this was a clinical audit.
FINANCIAL SUPPORTNo funding was acquired or utilised for this report.